The Nexus of iron and inflammation in hepcidin regulation: SMADs, STATs, and ECSIT

Hepatology

Volumn 45, Issue 1, 2007, Pages 253-256

  Milward, Elizabeth ^a   Johnstone, Daniel ^a   Trinder, Debbie ^b   Ramm, Grant ^c   Olynyk, John ^b  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLPYRAZOLE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; CCAAT ENHANCER BINDING PROTEIN; CD71 ANTIGEN; FERRITIN; FERROPORTIN 1; HEPCIDIN; IRON; IRP PROTEIN 1; IRP PROTEIN 2; PROTEIN ECSIT; RNA BINDING PROTEIN; SMAD PROTEIN; STAT PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WNT2 PROTEIN;

ALCOHOL METABOLISM; BINDING AFFINITY; DOWN REGULATION; GENE ACTIVITY; GENETIC REGULATION; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; IRON TRANSPORT; NONHUMAN; NOTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TIGHT JUNCTION; UPREGULATION;

EID: 33846403691     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21526     Document Type: Note

References (31)

1. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut 2006;55:564-568.
2. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596-4601.
3. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003;361:669-673.
4. Lee P, Peng H, Gelbart T, Beutler E. The IL-6- and lipopolysaccharide- induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 2004;101:9263-9265.
5. Frazer DM, Wilkins SJ, Millard KN, McKie AT, Vulpe CD, Anderson GJ. Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE. Brit J Haematol 2004;126:434-436.
6. Constante M, Jiang W, Wang D, Raymond VA, Bilodeau M, Santos MM. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. Am J Physiol Gastrointest Liver Physiol 2006;291:G229-G237.
7. Peyssonnaux C, Zinkamagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006;107:3727-3732.
8. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 2003;228:882-890.
9. Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, et al. Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. HEPATOLOGY 2005;41:545-552.
10. Lou DQ, Lesbordes JC, Nicolas G, Viatte L, Bennoun M, Van Rooijen N, et al. Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. HEPATOLOGY 2005;41:1056-1064.
11. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006;80:866-874.
12. Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res 2006;30:106-112.
13. Jiang W, Sun R, Wei H, Tian Z. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci U S A 2005;102:17077-17082.
14. Gehrke SG, Herrmann T, Kulaksiz H, Merle U, Bents K, Kaiser I, et al. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 2005;72:25-32.
15. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005;105:1803-1806.
16. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 2005;105:376-381.
17. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006;281:28494-28498.
18. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
19. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-539.
20. Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A 2006;103:10289-10293.
21. Zhang AS, West AP Jr, Wyman AE, Bjorkman PJ, Enns CA. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem 2005;280:33885-33894.
22. Xiao C, Shim JH, Kluppel M, Zhang SS, Dong C, Flavell RA, et al. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev 2003;17:2933-2949.
23. Moustakas A, Heldin CH. Ecsit-ement on the crossroads of Toll and BMP signal transduction. Genes Dev 2003;17:2855-2859.
24. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006;108:3204-3209.
25. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stoke J, Hentze MW, Muckenthaler MU. STAT-3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2006;[Aug 31, Epub ahead of print].
26. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999;397:710-713.
27. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 1999;284:479-482.
28. Long J, Wang G, Matsuura I, He D, Liu F. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc Natl Acad Sci U S A 2004;101:99-104.
29. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-1866.
30. Beutler E, Waalen J, Gelbart T. Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype. Blood Cells Mol Dis 2005;35:326-327.
31. Aloka CA, Rossaro L, Ramsamooj R, Brandhagen D, Burritt MF, Bowlus CL. Liver Hepcidin mRNA correlates with iron stores but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 2005;39:71-74.